Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MannKind Corp

+ Add to Watchlist


4.3700 USD 0.1900 4.55%

As of 20:10:00 ET on 05/04/2015.

Company Profile for MannKind Corp (MNKD)

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.

Contact Information

MannKind Corp

28903 North Avenue Paine
Valencia, CA 91355
United States
Phone: 1-661-775-5300
Fax: 1-661-775-2081

Key Executives for MannKind Corp (MNKD)

Alfred E MannChairmanHakan S EdstromPresident/CEO
Matthew J Pfeffer "Matt"VP/CFO/Investor RelationsJuergen A MartensVP/COO
David B ThomsonVP/Secy/General CounselDiane M PalumboVP:Human Resources

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil